{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:16:17Z","timestamp":1778915777221,"version":"3.51.4"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T00:00:00Z","timestamp":1456099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149521","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T14:25:19Z","timestamp":1456151119000},"page":"e0149521","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection"],"prefix":"10.1371","volume":"11","author":[{"given":"Lauren","family":"Lapointe-Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim L.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Coyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Hancock-Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Powis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Poutanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susy","family":"Hota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","article-title":"Clostridium difficile-associated diarrhea in adults","volume":"171","author":"SM Poutanen","year":"2004","journal-title":"CMAJ"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0196-6553(95)90060-8","article-title":"Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients","volume":"23","author":"LV McFarland","year":"1995","journal-title":"Am J Infect Control"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","article-title":"Clostridium difficile colitis","volume":"330","author":"CP Kelly","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"SH Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"24","key":"ref5","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","article-title":"A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease","volume":"271","author":"LV McFarland","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0016-5085(80)90851-3","article-title":"Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis","volume":"78","author":"JG Bartlett","year":"1980","journal-title":"Gastroenterology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea","volume":"22","author":"C Wenisch","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/501553","article-title":"Recurrent Clostridium difficile disease: epidemiology and clinical characteristics","volume":"20","author":"LV McFarland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"E van Nood","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"LV McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"ref11","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/cid\/cis499","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials","volume":"55","author":"DW Crook","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"OA Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"TJ Louie","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Z Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref15","unstructured":"Ministry of Health and Long-term Care. Exeptional Acces Program Reimbursement Criteria for Frequently Requested Drugs. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/pdf\/frequently_requested_drugs.pdf\" xlink:type=\"simple\">http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/pdf\/frequently_requested_drugs.pdf<\/ext-link>."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2458-10-133","article-title":"Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial","volume":"10","author":"A Ahmad","year":"2010","journal-title":"BMC Public Health"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/cit346","article-title":"Is fidaxomicin worth the cost? An economic analysis","volume":"57","author":"SM Bartsch","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1155\/2014\/793532","article-title":"Clinical and economic consequences of vancomycin and fidaxomicin for the treatment of Clostridium difficile infection in Canada","volume":"25","author":"M Wagner","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1155\/2012\/213828","article-title":"A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics","volume":"26","author":"E Allen-Vercoe","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"ref20","unstructured":"Health Canada. Fecal Microbiota Therapy Used in the Treatment of Clostridium difficile Infection Not Responsive to Conventional Therapies Ottawa, Canada2015."},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1155\/2014\/403828","article-title":"Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection","volume":"28","author":"JS Zipursky","year":"2014","journal-title":"Canadian Journal of Gastroenterology & Hepatology"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/cid\/ciu128","article-title":"Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis","volume":"58","author":"GG Konijeti","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref23","unstructured":"Gravel D, Miller M. Clostridium difficile Associated Diarrhea in Acute-Care Hospitals Participating in CNISP: November 1, 2004 to April 30, 2005. 2007."},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jinf.2007.09.015","article-title":"Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system","volume":"55","author":"J Belmares","year":"2007","journal-title":"J Infect"},{"issue":"Suppl 2","key":"ref25","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55","author":"OA Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/0272989X13501558","article-title":"The half-cycle correction revisited: redemption of a kludge","volume":"33","author":"DM Naimark","year":"2013","journal-title":"Med Decis Making"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jval.2012.06.016","article-title":"Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20142","volume":"15","author":"M Roberts","year":"2012","journal-title":"Value Health"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/501126","article-title":"Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada","volume":"42","author":"J Pepin","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1086\/522676","article-title":"The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences","volume":"28","author":"JA O'Brien","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"SB Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2012.01.004","article-title":"Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence","volume":"40","author":"KZ Vardakas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection","volume":"172","author":"Z Kassam","year":"2012","journal-title":"Arch Intern Med"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/hcp118","article-title":"Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series","volume":"102","author":"AA MacConnachie","year":"2009","journal-title":"QJM"},{"issue":"11\u201312","key":"ref34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3109\/00365548.2010.499541","article-title":"Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea","volume":"42","author":"K Garborg","year":"2010","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"J Aas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2011.11.037","article-title":"Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection","volume":"142","author":"E Mattila","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MCG.0b013e3181dadb10","article-title":"Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology","volume":"44","author":"F Rohlke","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCG.0b013e3181dac035","article-title":"Treatment of refractory\/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients","volume":"44","author":"SS Yoon","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCG.0b013e318234570b","article-title":"Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results","volume":"46","author":"CR Kelly","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"ref40","first-page":"1027","article-title":"Clostridium difficile-associated diarrhea treated with homologous feces","volume":"118","author":"S Lund-Tonnesen","year":"1998","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.mayocp.2013.04.022","article-title":"Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience","volume":"88","author":"NC Patel","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ajg.2012.60","article-title":"Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection","volume":"107","author":"LJ Brandt","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref43","first-page":"89","article-title":"Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection\u2014results and follow-up","volume":"104","author":"MH Mellow","year":"2011","journal-title":"J Okla State Med Assoc"},{"issue":"Suppl 2","key":"ref44","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/cis356","article-title":"Predictors of first recurrence of Clostridium difficile infection: implications for initial management","volume":"55","author":"DW Eyre","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref45","unstructured":"Statistics Canada. Table 7a Complete life table, males, Canada, 2009 to 2011: Minister of Industry,; 2015 [cited 2015 October 22]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.statcan.gc.ca\/pub\/84-537-x\/2013005\/tbl-eng.htm\" xlink:type=\"simple\">http:\/\/www.statcan.gc.ca\/pub\/84-537-x\/2013005\/tbl-eng.htm<\/ext-link>."},{"key":"ref46","unstructured":"Statistics Canada. Table 7a Complete life table, females,Canada, 2009 to 2011 <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.statcan.gc.ca\/pub\/84-537-x\/2013005\/tbl-eng.htm:\" xlink:type=\"simple\">http:\/\/www.statcan.gc.ca\/pub\/84-537-x\/2013005\/tbl-eng.htm:<\/ext-link> Ministry of Industry,; 2015 [cited 2015 October 22]."},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-145-12-200612190-00004","article-title":"Complications of Colonoscopy in an Integrated Health Care Delivery System","volume":"145","author":"TR Levin","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/cc120","article-title":"A prospective study of tracheopulmonary complications associated with the placement of narrow-bore enteral feeding tubes","volume":"2","author":"AJ Rassias","year":"1998","journal-title":"Crit Care"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/cid\/cit127","article-title":"Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection","volume":"56","author":"AS Walker","year":"2013","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1155\/2008\/854984","article-title":"The costs of colonoscopy in a Canadian hospital using a microcosting approach","volume":"22","author":"N Sharara","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"ref51","unstructured":"Ontario Ministry of Health and Long-Term Care. Ontario Case Costing Initiative 2013 [December 15, 2013]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.occp.com\/mainPage.htm\" xlink:type=\"simple\">http:\/\/www.occp.com\/mainPage.htm<\/ext-link>."},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: using national measures to create condition-specific values","volume":"36","author":"MR Gold","year":"1998","journal-title":"Med Care"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00019053-199915040-00004","article-title":"Utility scores for chronic conditions in a community-dwelling population.","volume":"15","author":"N Mittmann","year":"1999","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Z Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref55","unstructured":"Statistics Canada. Consumer Price Index, health and personal care, by province (Canada) 2015 [12 November, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/econ161a-eng.htm\" xlink:type=\"simple\">http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/econ161a-eng.htm<\/ext-link>."},{"key":"ref56","unstructured":"Monthly Average Exchange Rates: 10-Year Lookup [Internet]. 2013 [cited 12 November, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.bankofcanada.ca\/rates\/exchange\/monthly-average-lookup\/\" xlink:type=\"simple\">http:\/\/www.bankofcanada.ca\/rates\/exchange\/monthly-average-lookup\/<\/ext-link>."},{"key":"ref57","unstructured":"Ministry of Health and Long Term Care. Schedule of Benefits. Toronto, Ontario: Province of Ontario; 2013."},{"key":"ref58","unstructured":"U.S. National Institutes of Health. Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin NCT01226992: ClinicalTrials.gov; 2013 [cited 2014 June 16]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01226992\" xlink:type=\"simple\">http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01226992<\/ext-link>."},{"key":"ref59","unstructured":"Ontario Nurses&apos; Association. Unions and the Ontario Nurses\u2019 Association 2014 [cited 2014 March 30]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ona.org\/faqs.html#f15\" xlink:type=\"simple\">http:\/\/www.ona.org\/faqs.html#f15<\/ext-link>."},{"key":"ref60","unstructured":"Government of Canada. Explore Careers- Wage Report <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.workingincanada.gc.ca\/:\" xlink:type=\"simple\">http:\/\/www.workingincanada.gc.ca\/:<\/ext-link> Government of Canada; 2013 [updated 2013; cited 2014 February 4]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.workingincanada.gc.ca\/LMI_report_area.do?reportOption=wage&PROVINCE_ID=35&GEOAREA_CD=9219&selectLocation=Continue\" xlink:type=\"simple\">http:\/\/www.workingincanada.gc.ca\/LMI_report_area.do?reportOption=wage&amp;PROVINCE_ID=35&amp;GEOAREA_CD=9219&amp;selectLocation=Continue<\/ext-link>."},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jval.2012.11.004","article-title":"Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States","volume":"16","author":"PM Stranges","year":"2013","journal-title":"Value Health"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10198-012-0441-4","article-title":"Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information","volume":"14","author":"L Mohseninejad","year":"2013","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"key":"ref63","unstructured":"Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada. Ottawa: 2006."},{"issue":"3","key":"ref64","first-page":"17","article-title":"Money Left on the Table: Generic Drug Prices in Canada","volume":"8","author":"MR Law","year":"2013","journal-title":"Healthcare Policy"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/501553","article-title":"Recurrent Clostridium difficile Disease: Epidemiology and Clinical Characteristics","volume":"20","author":"V Lynne","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jamcollsurg.2013.05.028","article-title":"Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy","volume":"217","author":"WJ Halabi","year":"2013","journal-title":"J Am Coll Surg"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/596703","article-title":"Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study","volume":"48","author":"D Gravel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref68","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jamcollsurg.2014.01.053","article-title":"Epidemiology and Outcomes of Community-Acquired Clostridium difficile Infections in Medicare Beneficiaries","volume":"218","author":"CE Collins","year":"2014","journal-title":"J Am Coll Surg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T17:43:29Z","timestamp":1567619009000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149521"}},"subtitle":[],"editor":[{"given":"Abhishek","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149521","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]}}}